| Market Cap | 61.11M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -6.44M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -2.00% |
| Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | -14.00% |
| Dividend | N/A | Price/Book | 0.57 | EPS next 5Y | - | 52W High Chg | -65.00% |
| Recommedations | - | Quick Ratio | 2.13 | Shares Outstanding | 8.59B | 52W Low Chg | 26.00% |
| Insider Own | 11.64% | ROA | -3.94% | Shares Float | 7.68B | Beta | 0.48 |
| Inst Own | 2.83% | ROE | -7.81% | Shares Shorted/Prior | -/- | Price | 0.00800 |
| Gross Margin | - | Profit Margin | - | Avg. Volume | 8,521 | Target Price | - |
| Oper. Margin | - | Earnings Date | Sep 22 | Volume | 1,000 | Change | 0.00% |
Lepidico Limited engages in the exploration, development, and production of lithium chemicals in Australia, Canada, Africa, the United Arab Emirates, Europe, and internationally. The company operates through two segments, Mineral Exploration and Phase 1 Chemical Plant. Its technologies include L-Max technology, a process for converting lithium-mica minerals to lithium and other useful by-products; and LOH-Max process, which produces high quality lithium hydroxide from lithium sulphate. In addition, it holds an 80% interest in the Karibib project located in Namibia. Lepidico Limited was incorporated in 1979 and is based in West Perth, Australia.
